Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
44.75    2.25 (5.29%)
Bid:
44.50
Ask:
45.00
Spread: 0.50 (1.124%)
Market Cap: £85.86m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Trading Update

14 Dec 2015 07:00

RNS Number : 8858I
Iofina PLC
14 December 2015
 

 

14 December 2015

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Oklahoma Operations Update

Full year production up 75% year on year

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, notes the recent decline in the Company's share price and provides the following update on the Company's iodine production in the State of Oklahoma in order to reassure and update shareholders on the Company's current operations.

 

The Board confirms that, despite production levels being impacted by downtime due to its partners' work on the Salt Water Disposal ("SWD"), coupled with recent weather-related power outages, Iofina expects to meet its forecasts and produce between 276-286 metric tonnes ("MT") of crystalline iodine in H2 2015, resulting in full year production of 570 to 580 MT of crystalline iodine (2014: 328 MT), a like-for-like increase of 75%.

As reported on 23 November 2015, the Company informed the market of actions taken by the Oklahoma Corporation Commission ("OCC") with respect to curtailing some SWD Injection Wells in areas where larger magnitude seismic activity had recently occurred. Currently Iofina's two partners are disposing of in excess of 500,000 barrels of brine water per day ("bwpd") in the Mississippi Lime play. Iofina is currently processing near 100,000 bwpd. Thus, there is an abundant source of brine in the area of the Company's production. Although seismic activity continues in Oklahoma, resulting in the OCC issuing further restrictions for some SWDs located east of the Company's production area, the Board is pleased to report that this does not directly affect the SWDs at the sites of Iofina's IOsorb® plants. 

Iofina's partners continue to expand operations in the Company's production area with relative downtime at plants IO#4 and IO#6 recently due to brine diversion for fracturing operations. Since the initial OCC restrictions, the Company has seen a decrease in brine available at IO#3 and IO#5. Although this is anticipated to continue in the near term, brine availability is expected to be only marginally down year-on-year.

The Company confirms that its other sites currently remain unaffected, but continues to consult with its partners about the possible effects of OCC restrictions. The Company expects the current reduction in injection volumes, if sustained, would result in 2016 full year production from its current plants being flat to 10% down year-on-year. The Company will update the market as this matter becomes clearer.

For the long term, Iofina is working closely with its partners to investigate other means to access brine water at its plants, which would avoid the need for direct association with particular SWDs. The Company has successfully piloted an alternative brine supply mechanism during a recent workover of one of its partner's SWDs this summer. Additionally, continued efficiencies in Iofina's process and reduction in Company costs of extraction will further mitigate the potential reduction in brine supply.

 

 

Commenting, President and CEO Tom Becker stated:

"I wish to reassure all shareholders that the Company has done all it can to mitigate further impact resulting from the seismic activity reported last month. It is encouraging that, despite this activity, the Company will achieve this year's target production figure, which is itself up 75% year-on-year.

"While there is brine loss, our production levels are expected to be broadly flat in 2016. We continue to work closely with our partners, pending the outcome of discussions with the OCC to source alternative supplies. The Board acknowledges the disappointing decline in the share price but reaffirms that that the Company is operationally robust."

 

For further information, please contact:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Rob Collins/Emily Morris

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDFDLVLIE
Date   Source Headline
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSPPP Loan Received
4th May 20207:00 amRNSIO#8 Brine Supply Update
14th Apr 20207:00 amRNSQ1 Market Update
2nd Apr 20207:00 amRNSDirectorate Change
26th Mar 20201:53 pmRNSWithdrawal of requisition for General Meeting
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 20204:41 pmRNSSecond Price Monitoring Extn
12th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20201:56 pmRNSClarification Regarding Media Reports
11th Mar 202012:08 pmRNSSecond Price Monitoring Extn
11th Mar 202012:02 pmRNSPrice Monitoring Extension
10th Mar 20207:30 amRNSBoard response to recent GM request
10th Mar 20207:00 amRNSRequisition of General Meeting
3rd Mar 20207:10 amRNSStatement re: press and social media reports
2nd Mar 202012:22 pmRNSHolding(s) in Company
25th Feb 202012:00 pmRNSMarket Update
10th Feb 20205:15 pmRNSHolding(s) in Company
10th Feb 20205:15 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSMarket Update - Strong H2 2019
2nd Jan 202011:11 amRNSHolding(s) in Company
20th Dec 20197:00 amRNSTrading Update
14th Nov 20193:51 pmRNSHolding(s) in Company
14th Nov 20193:50 pmRNSHolding(s) in Company
12th Nov 20191:43 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSIofinaEX Hemp Seed Investment
14th Oct 20197:00 amRNSQ3 2019 Update
26th Sep 201910:00 amRNSHolding(s) in Company
25th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
18th Sep 20197:00 amRNSTerms for IO#8 Finalised - Construction Commences
29th Aug 20194:41 pmRNSSecond Price Monitoring Extn
29th Aug 20194:35 pmRNSPrice Monitoring Extension
13th Aug 20197:00 amRNSIncorporation of IofinaEX Global
29th Jul 20197:00 amRNSGrant of Share Options
24th Jul 20193:08 pmRNSHolding(s) in Company
16th Jul 20192:17 pmRNSHolding(s) in Company
12th Jul 20197:00 amRNSH1 2019 Update
17th Jun 20191:49 pmRNSHolding(s) in Company
17th Jun 201910:55 amRNSHolding(s) in Company
17th Jun 201910:53 amRNSHolding(s) in Company
13th Jun 201912:00 pmRNSResult of AGM and Open Offer
13th Jun 20197:00 amRNSIofinaEX Application Conditionally Approved
20th May 20197:00 amRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.